Contains viable, selected strains of human adenovirus type 4 and human adenovirus type 7 prepared in human-diploid fibroblast cell cultures (strain wi-38); virus strains have not been attenuated; cells are grown and the virus growth maintained in dulbecco's modified eagle's medium, fetal bovine serum, and sodium bicarbonate; approved for use in military populations 17-50 years of age; indicated for active immunization for the prevention of febrile acute respiratory disease caused by adenovirus type 4 and type 7; carton consists of one bottle of 100 tablets adenovirus type 4 (ndc 51285-174-02) and one bottle of 100 tablets adenovirus type 7 (ndc 51285-175-02); store refrigerated between 2-8 degrees c (35-46 degrees f); do not freeze; keep bottle tightly closed and protect from moisture; do not remove desiccant canister from bottle; prescription only; for oral administration; dosage: one tablet of adenovirus type 4 component and one tablet of adenovirus type 7 component
NSN 6650-01-476-3329
NSN 6620-01-169-2406
NSN 5920-00-373-3636
NSN 5945-01-099-5155
NSN 5950-01-246-6709
NSN 5975-00-936-9549
NSN 5905-00-021-2353
NSN 5950-00-484-3149
NSN 5925-00-960-5214
NSN 6135-01-270-8601
NSN 6620-00-309-9920
NSN 6610-00-155-1334